153294-01-0

Basic information

• Product Name: methyl (2R)-{[tert-butyl(dimethyl)silyl]oxy}(3-chlorophenyl)ethanoate
• Synonyms: methyl (2R)-{[tert-butyl(dimethyl)silyl]oxy}(3-chlorophenyl)ethanoate
• CAS NO: 153294-01-0
• Molecular Weight: 314.884
• Mol File: 153294-01-0.mol

Chemical Properties

• CAS DataBase Reference: methyl (2R)-{[tert-butyl(dimethyl)silyl]oxy}(3-chlorophenyl)ethanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (2R)-{[tert-butyl(dimethyl)silyl]oxy}(3-chlorophenyl)ethanoate(153294-01-0)
• EPA Substance Registry System: methyl (2R)-{[tert-butyl(dimethyl)silyl]oxy}(3-chlorophenyl)ethanoate(153294-01-0)

Safety Data

• Hazardous Substances Data: 153294-01-0(Hazardous Substances Data)

Upstream product

• 16273-37-3 (R)-3-chloromandelic acid 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 153294-00-9 (R)-3-chloromandelic acid methyl ester 

Downstream Products

• 167849-13-0 methyl (2R)-2-{[(2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl]amino}propanoate 
• 1429383-35-6 tert-butyl 2-((2R,5R,6R)-6-(3-chlorophenyl)-4-(cyclopropylmethyl)-3-oxo-5-((phenylsulfonyl)-1H-indol-2-yl)morpholin-2-yl)acetate 
• 1429383-36-7 tert-butyl 2-((2S,5R,6R)-6-(3-chlorophenyl)-4-(cyclopropylmethyl)-3-oxo-5-((phenylsulfonyl)-1H-indol-2-yl)morpholin-2-yl)acetate 
• 1429383-33-4 (1R,2R)-2-(tert-butyldimethylsilyloxy)-2-(3-chlorophenyl)-N-(cyclopropylmethyl)-1-(1-(phenylsulfonyl)-1H-indol-2-yl)ethanamine 
• 1429383-32-3 (1R,2R)-2-(tert-butyldimethylsilyloxy)-2-(3-chlorophenyl)-1-(1-(phenylsulfonyl)-1H-indol-2-yl)ethanamine 
• 1429383-31-2 (R)-N-((1R,2R)-2-(tert-butyldimethylsilyloxy)-2-(3-chlorophenyl)-1-(1-(phenylsulfonyl)-1H-indol-2-yl)ethyl)-2-methylpropane-2-sulfinamide 
• 1429383-30-1 (R)-N-((R)-2-(tert-butyldimethylsilyloxy)-2-(3-chlorophenyl)ethylidene)-2-methylpropane-2-sulfinamide 
• 153294-02-1 (R)-2-(tert-butyldimethylsilyloxy)-2-(3-chlorophenyl)acetaldehyde 
• 1026596-90-6 [2-(tert-butyl-dimethyl-silanyloxy)-2-(3-chloro-phenyl)-ethyl]-(1-methyl-2-{4-[2-oxo-2-(toluene-4-sulfonylamino)-ethyl]-phenylamino}-ethyl)-carbamic acid tert-butyl ester 
• 1028300-56-2 C₃₆H₅₁ClN₄O₆SSi 
• 402509-10-8 tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl{(1R)-1-methyl-2-[4-(2-{[(4-methylphenyl)sulfonyl]amino}ethyl)anilino]ethyl}carbamate 
• 402509-08-4 tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl[(1R)-1-methyl-2-(4-{2-[(4-methylbenzyl)amino]-2-oxoethyl}anilino)ethyl]carbamate 
• 402508-97-8 tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl-((1R)-1-methyl-2-{4-[2-oxo-(1,3-thiazol-2-ylamino)ethyl]anilino}ethyl)carbamate 
• 402508-99-0 tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl[(1R)-1-methyl-2-(4-{2-[(methylsulfonyl)amino]-2-oxoethyl}anilino)ethyl]carbamate 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

The present invention provides MDM2 inhibitor compounds of Formula I or II, or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective β3 adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the ani